StockData

INVE Technologies vs TransAct Technologies

INVE and TACT side by side, both in computer and office equipment. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How INVE and TACT compare

INVE Technologies is the larger company, worth 1.3 times as much as TransAct Technologies ($62.5M against $47.3M).

TransAct Technologies grew revenue faster over the last twelve months (10.5% versus 3.1% for INVE Technologies).

TransAct Technologies keeps more of each dollar of sales as profit, with a net margin of −0.75% compared with −62.9% at INVE Technologies.

TransAct Technologies scores higher on the StockData Score (10 against 7 for INVE Technologies), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricINVETACT
Size and price
Market cap$62.5M$47.3M
Share price$2.58$4.58
Change, 1 year−26.7%8.5%
Change, 5 years−88.3%−61.8%
Beta (5Y)0.900.92
Employees155103
StockData Score
Total score710 (better)
Valuation score11
Growth score12 (better)
Performance score01 (better)
Health score56 (better)
Dividend score00
Valuation
P/S2.6×0.9× (better)
P/B0.5× (better)1.4×
EV/EBITDA–140×
P/FCF–9.0×
FCF yield−14.7%11.1% (better)
Fair value–$3.86
Margin of safety–−18.7%
Growth
Revenue growth (TTM)3.1%10.5% (better)
Revenue growth, 5Y average−24.4%11.0% (better)
Net income growth (TTM)−120%–
EPS growth (TTM)−121%–
Profitability
Gross margin15.9%49.6% (better)
Operating margin−82.4%−0.80% (better)
Net margin−62.9%−0.75% (better)
FCF margin−37.9%9.9% (better)
Return on equity−10.9%−1.3% (better)
Return on invested capital−103%−2.5% (better)
Financial health
Debt / equity0.000.00
Current ratio20.35 (better)2.65
Altman Z-score2.073.26 (better)
Piotroski F-score35 (better)
Dividends and buybacks
Shareholder yield0.00%0.00%
Ownership
Held by institutions40.8%38.0%
Held by insiders31.9%62.0%
Insider net buying, 12 months–$351K
Short interest, % of float1.1%0.70%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.